A&G PHARMACEUTICAL, INC.
US UEI SN6SWFABJXL1 · SME
16public awards
$12.3Mtotal public funding
2026-07-17latest award
State aid awards (16)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-07-17 | $2.0M | Grant | CANCER TREATMENT RESEARCH | Department of Health and Human Services |
| 2020-09-01 | $1.9M | Grant | Pharmacology and human Phase 1 safety and dose escalation studies usin | Department of Health and Human Services |
| 2018-09-01 | $1.3M | Grant | A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer | Department of Health and Human Services |
| 2018-09-01 | $159k | Grant | Pharmacology & human Phase 1 safety & dose escalation studies using an | Department of Health and Human Services |
| 2017-09-15 | $2.0M | Grant | Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safe | Department of Health and Human Services |
| 2017-03-15 | $153k | Grant | A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer | Department of Health and Human Services |
| 2015-01-01 | $1.0M | Grant | IGF OT IGF SMART FUSION HIGH AFFINITY PEPTIDE CAPTURE REAGENTS | Department of Health and Human Services |
| 2014-01-01 | $1.5M | Grant | Title: Development of Novel Anticancer Agent to potentiate sensitivity | Department of Health and Human Services |
| 2013-01-01 | $200k | Grant | IGF::OT::IGF Title: SMART Fusion: High Affinity Peptide Capture Reagen | Department of Health and Human Services |
| 2012-01-01 | $199k | Grant | NOVEL AGENT TO RESTORE SENSITIVITY TO ANTI-ESTROGEN THERAPY | Department of Health and Human Services |
| 2012-01-01 | $194k | Grant | Targeted Therapy for Non Small Cell Lung Carcinoma: In vivo Feasibilit | Department of Health and Human Services |
| 2011-01-01 | $113k | Grant | Serum GP88 biomarker as a surrogate marker for disease progression in | Department of Health and Human Services |
| 2010-01-01 | $1.2M | Grant | Novel Targeted Therapy for Breast Cancer | Department of Health and Human Services |
| 2009-01-01 | $184k | Grant | Novel Small Molecule Inhibitor of Rheumatoid Arthritis | Department of Health and Human Services |
| 2007-01-01 | $121k | Grant | Novel Targeted Therapy for Breast Cancer | Department of Health and Human Services |
| 2004-01-01 | $100k | Grant | Development of a novel serum diagnosis for breast cancer | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →